Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Ipca Labs is setting up API manufacturing facility in Dewas, MP
It is in the process of procuring environmental clearance for the new plant which is being built with an initial capital outlay of…
Scientists ascertain 73 novel variants of COVID-19 strain in Odisha
The research team, which carried out sequencing of 1,536 samples including 752 clinical samples, reported two lineages -- B.1.112…
NPPA issues final guidelines to discontinue making medicines under price control
The NPPA website will be uploading the list of applications filed by pharma companies and approved by the competent authority for…
US FDA approves Enspryng from Genentech for neuromyelitis optica spectrum disorder
In two randomised controlled Phase III clinical trials, SAkuraStar and SAkuraSky studies, Enspryng demonstrated robust and…
Russia begins production of COVID-19 vaccine
It would be producing about five million doses a month by December-January, Interfax said
Pharma-telehealth partnerships: Rules of the game
Industry advisors outline the legal aspects that need to be considered and fulfilled as pharma and telehealth players get into…
Sai Life Sciences opens Research & Technology Centre in Hyderabad
The company, through an initiative named Sai Nxt, is investing over $150 million (> Rs 1000 crores) to expand and upgrade its…
AYUSH Ministry launches campaign for awareness on affordable immunity boosting practices
‘AYUSH for Immunity’ was launched through a webinar, staged on AYUSH Virtual Convention Centre (AVCC), the new digital…
COVID-19 disrupted clinical trials with suspended enrollment more likely to resume: GlobalData
The number of trials that have been impacted by slow enrollment has increased by 13.9 per cent
Roadmap to distribute COVID-19 vaccines to Indians is ready: PM Modi
Three potential indigenous vaccines under development and as soon as scientists give the go-ahead, the country is ready for mass…